We thank Dr. Ellen R. Richie (University of Texas, MD Anderson Cancer Center, Science Park Research Division, Smithville, TX) and Dr. Lauren Ehrlich (University of Texas, Austin TX) for reading the manuscript, and Julie Nelson (University of Georgia, Center for Tropical and Emerging Global Diseases Flow Cytometry Facility, Athens, GA) for help with cell sorting.
To determine if the heightened disease severity and MCP-1 production in IL-6KO mice reflected an increase in mononuclear cell infiltration in the heart during the initiation of disease, flow cytometry was used to directly characterize the immune cells infiltrating the heart (day 7 PI).
In men with coronary artery disease flow-mediated vasodilatation was observed after 12 weeks (61).
In this review, we present the current knowledge of human B-cell subsets and their analysis in rheumatic diseases using flow cytometry.
A typical epidemic often involves the transmission of a disease, the flow of information regarding the disease, and the spread of human preventive behaviors against the disease.
Novel agents, in particular bortezomib and lenalidomide, have well documented potent synergistic activity with alloreactive T cells post allograft and may provide a platform for enhancing tumor control post allograft, particularly in those patients with high-risk disease in CR or with minimal residual disease on flow cytometry or PCR.
For untold millennia, this was the rule, not the exception: Diseases that flowed in the wake of armed conflict would often claim more lives than combat.
With the development of novel technologies, more sensitive detection of residual disease using flow cytomery and next generation sequencing has been possible.
In situations where the maneuver of manual compression of the abdomen is impossible to perform or unreliable, it may be reasonable to assume that most of patients with chronic obstructive disease suffer flow limitation [18, 26].
It has been shown that in the absence of macroscopic coronary artery disease, global flow reserve can be impaired in heart failure as a consequence of microvascular dysfunction.
Risk factors considered for risk assignment were the need for two induction courses to achieve CR, detectable minimal residual disease by flow cytometry after intensification therapy (AML-03), and presence of FLT3-ITD (AML-03).
